Yazar "Tunc, S. Yaman" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • [ X ]
    Öğe
    Prevalence and types of cervical human papillomavirus among Turkish women and its relationship with demographic factors in a gynecology outpatient clinic
    (I R O G Canada, Inc, 2016) Tunc, S. Yaman; Onan, M. A.; Turp, A. B.; Kusvuran, E. Demir; Fidans, I.; Guner, H.
    Purpose of investigation: The purpose of this study was to determine the prevalence of various human papillomavirus (HPV) types and its relationship with some risk factors among Turkish women. Materials and Methods: A total of 673 patients were included in the study. Cervical samples were taken from the patients for routine Pap smear and HPV DNA tests. HPV DNA was studied in the cervical smear by using the PCR method. Results: The mean age of the patients was 40 +/- 10.9 years. Of all patients, 13.5% had a positive HPV DNA test. In addition, 5.1% of the patients were HPV type 16 positive, 1.5% were HPV type 18 positive, 0.6% were HPV type 31 positive, and 0.9% were HPV type 53 positive. Conclusion: Findings show that awareness should be raised among Turkish women regarding HPV infection and vaccination.
  • [ X ]
    Öğe
    The relationship between complete hydatidiform mole and serum Vitamin D level: a prospective case-control study
    (Verduci Publisher, 2022) Gunduz, R.; Deger, U.; Kaplan, I; Tepe, N. Bayramoglu; Tunc, S. Yaman; Icen, M. S.; Agacayak, E.
    OBJECTIVE: This study aimed to determine whether or not there was a relations-hip between complete hydatidiform mole (CHM) and serum Vitamin D level by comparing CHM patients with two control groups and to determi-ne whether or not Vitamin D deficiency is a risk factor for CHM. PATIENTS AND METHODS: This prospec-tive study included 30 patients diagnosed with CHM (case group), 30 patients in the first trimes-ter of a healthy pregnancy (control group), and 30 healthy non-pregnant subjects (control group). A record was made of serum 25-hydroxyvitamin D (25-OH D vitamin) levels, age, body mass index (BMI), gravida, parity, and the number of abortus. The serum 25-OH D vitamin levels were examined in each group and compared between groups. RESULTS: The 25-OH D vitamin level of all the patients in the study was determined as 11.16 +/- 8.64 ng/mL. No significant difference was determined between the groups in respect of 25 OH-D vitamin levels. When comparisons were made between the four subgroups according to the 25-OH-D level, no significant difference was determined between the CHM and control groups. When the patients were separated as obese and non-obese groups, no significant dif-ference was determined between the groups. CONCLUSIONS: Severe deficiency, deficien-cy, or insufficient levels of serum Vitamin D are not thought to be risk factors for CHM patients.